Chemical Price | Prices | Pricing | Monitoring | ChemAnalyst

For the Quarter Ending September 2023 North America In July,  Levofloxacin Hemihydrate prices  experienced a significant decline of 3.76%, followed by a marginal increase of 1.61% in August and a modest rise of 0.43% in September. During July, new order inquiries and sales dwindled due to weak domestic and global demand, exacerbated by the Federal Reserve's decision to raise its key policy interest rate by a quarter percentage point—its highest level in 22 years. This move reduced overall demand in the economy, supporting the downward trend in Levofloxacin Hemihydrate prices. However, prices rebounded in August and September, driven by a surge in energy prices, which escalated overall business expenses and transportation costs. Gasoline prices rose as Russia and Saudi Arabia implemented aggressive supply cuts, propelling crude oil to a 10-month high of $91 per barrel. Additionally, a decrease in imports from major exporting countries like China limited the supply of Levofloxac...

  For the Quarter Ending June 2023 North America: In the United States,  Levofloxacin Hemihydrate prices  saw a 1.70 percent increase in June compared to April. The US manufacturing PMI (Purchasing Managers Index) declined to 46.3 in June, down from 48.4 in May and 47.1 in April. This indicated limited inventories among market suppliers and traders, coupled with supplier delivery delays to meet consumer demand, which bolstered Levofloxacin Hemihydrate prices. Additionally, growing market optimism stemmed from heightened consumer interest and supply shortages, prompting traders to raise their prices and focus on restocking. The consumer price index (CPI), a measure of inflation, rose by 0.2% in June, up from 0.1% in May, suggesting a moderation in June's inflation due to a US Federal Reserve interest rate hike. Despite the lower inflation rate, prices remained elevated, hinting at potential rate hikes in the third quarter. Import momentum remained steady, providing support...